mifepristone has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chadwick, CC; Hermsmeyer, K; Minshall, RD; Miyagawa, K; Novy, MJ | 1 |
Baker, PN; Farrow, SN; Jones, RL; Nugent, JL; Palin, V; Ray, DW; Sibley, CP; Wareing, M | 1 |
2 other study(ies) available for mifepristone and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
Article | Year |
---|---|
In vitro modulation of primate coronary vascular muscle cell reactivity by ovarian steroid hormones.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Calcium Signaling; Coronary Vasospasm; Coronary Vessels; Disease Models, Animal; Disease Susceptibility; Enzyme Activation; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Hormone Antagonists; Hormone Replacement Therapy; Humans; Macaca mulatta; Microscopy, Confocal; Microscopy, Fluorescence; Mifepristone; Muscle Proteins; Muscle, Smooth, Vascular; Ovariectomy; Postmenopause; Progesterone; Protein Kinase C; Receptors, Estrogen; Receptors, Progesterone; Serotonin; Thromboxane A2; Vasoconstriction | 1998 |
Chronic glucocorticoid exposure potentiates placental chorionic plate artery constriction: implications for aberrant fetoplacental vascular resistance in fetal growth restriction.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arteries; Carbenoxolone; Chorion; Dexamethasone; Female; Fetal Growth Retardation; Glucocorticoids; Humans; Hydrocortisone; Mifepristone; Placenta; Placental Circulation; Pregnancy; Vasoconstriction; Vasodilation | 2013 |